STAT3 and non-small cell lung carcinoma: Studies have shown that the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway is overactive in NSCLC tissues and is closely associated with proliferation, angiogenesis, invasion, and migration of NSCLC cells [28].